Objective:

To evaluate the effectiveness of a fingerprick blood test for detecting Alzheimer's disease biomarkers and its potential impact on diagnostics.

Key Findings:

• Dried blood spot samples can accurately predict abnormal cerebrospinal fluid biomarkers indicating Alzheimer's pathology.
• Capillary p-tau217 levels increased with disease severity and showed good accuracy in detecting cerebrospinal fluid biomarker positivity.
• Preliminary data indicated high concordance between self-collected and professionally collected samples, although 15-25% of self-collections were unsuccessful due to insufficient blood flow or technical issues.

Interpretation:

The method could revolutionize Alzheimer's diagnostics by enabling home testing, significantly overcoming logistical barriers associated with traditional blood tests.

Limitations:

• Capillary samples showed lower diagnostic accuracy compared to venous blood, which may affect clinical decision-making.
• Standardized collection protocols need to be developed for clinical use to ensure reliability.

Conclusion:

While promising, the technique is best suited for research, population screening, and therapeutic trial recruitment rather than immediate clinical application, emphasizing the potential for home testing.